Veeva Systems (NYSE:VEEV) saw a 6% price increase last week, potentially influenced by the announcement of Tina Hunt's upcoming retirement from the board. This governance change may have reassured ...
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, ...
Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid fourth-quarter fiscal 2025 performance and strategic ...
Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first ...
We came across a bullish thesis on Veeva Systems Inc. (VEEV) on Substack by Francesco Ferrari. In this article, we will ...
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany and BARCELONA, Spain, March 11, 2025 /PRNewswire/ ...
Needham & Company LLC restated their buy rating on shares of Veeva Systems (NYSE:VEEV – Free Report) in a report released on ...
Stephens reissued their overweight rating on shares of Veeva Systems (NYSE:VEEV – Free Report) in a research note released on ...
Value investors believe that owning a stock is owning a slice of the underlying business… but this isn’t always true. Innovative corporate forms such as Special Purpose Vehicles (SPV) and (Variable ...
Veeva Systems aims to provide immediate value for commercial operations and data analytics teams via CRM Pulse, which provides quarterly HCP access data.
Veeva released Q4 result on March 5 th, reporting 14.3% revenue growth and 28.7% adj. operating profit growth, as detailed in ...
Veeva Systems (VEEV) is climbing 7% after delivering stronger-than-expected fourth-quarter results and providing full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results